Cite

HARVARD Citation

    Ng, C. et al. (n.d.). 211PAdjuvant axitinib in Asian vs non-Asian patients with metastatic renal cell carcinoma (mRCC): ATLAS trial subgroup analysis. Annals of oncology. p. . [Online]. 
  
Back to record